|
2025
|
G/S
|
Pharmaceutical research and development; Pharmaceutical products development; Veterinary research |
|
2024
|
Invention
|
Use of spla2 inhibitors to treat envenomation by snakes and wasps.
This disclosure provides medi... |
|
|
Invention
|
Use of spla2 inhibitors to treat hymenoptera envenomation, hemolysis, and kidney disease, and to ... |
|
2022
|
G/S
|
Pharmaceutical preparations, namely, antidotes Medical apparatus, namely, infusion and injection ... |
|
|
Invention
|
Compositions and dosage forms for topical and transdermal delivery of actives and methods of use.... |
|
2021
|
Invention
|
Envenomation therapies and related pharmaceutical compositions, systems and kits. 2 inhibitor), a... |
|
2020
|
Invention
|
Early management, mitigation and prevention of sepsis and sepsis-like syndromes, including neo-na... |
|
|
Invention
|
Early management and prevention of sepsis and sepsis-like syndromes. The present invention relate... |
|
2017
|
Invention
|
Pla2 inhibitors for treatment of pathological conditions caused by hymenoptera envenomation, such... |
|
|
Invention
|
Pla2 and hmg-coa inhibitors for treatment of pathological conditions causing hemolysis, cerebral ... |
|
2015
|
Invention
|
Envenomation therapies and related pharmaceutical compositions, systems and kits. The invention p... |
|
|
G/S
|
Antidotes. |
|
2013
|
Invention
|
Administration of acetylcholinesterase inhibitors to mitigate neurotoxin-induced paralysis and re... |
